Tag Archives: Rx prices

THANK YOU! Your action made change in Hartford!

VICTORIES FOR HEALTH CARE AT THE CAPITOL! THANK YOU TO ALL WHO TOOK ACTION! THANK YOU to all of you who called, emailed, shared alerts and posts, and worked to support important people-centered/pro-consumer health care bills this session. Here are some important … Continue reading

Posted in From the Foundation | Tagged , , , , , , , | Leave a comment

#Fight4Better is What We Need

By Lynne Ide Here we are in week three of the legislative session in Hartford.  What is going to happen with health care? All eyes have been focused on Washington, D.C. and the health care agendas put forth by President … Continue reading

Posted in Lynne Ide | Tagged , | Leave a comment

Are the ACA Marketplaces Fixable?

By Jill Zorn As discussed in a previous blog, the Affordable Care Act (ACA) marketplaces are struggling with lower than expected enrollment, sicker than expected customers, dwindling insurer competition and rising premiums in some regions of the country, including Connecticut. … Continue reading

Posted in From the Foundation, Jill Zorn | Tagged , , , | Leave a comment

The EpiPen Scandal: Don’t Mess with Parents! 

By Jill Zorn If it wasn’t for a grassroots movement of furious parents, we may never have heard about the EpiPen price gouging scandal. When parents of children with severe allergies started going to pharmacies in July to purchase their … Continue reading

Posted in Jill Zorn | Tagged | Leave a comment

Will Public Shaming be Enough to get Big Pharma to Lower Drug Prices? 

  By Jill Zorn  Consumers are losing ground as there continues to be inaction in addressing the unbridled growth of prescription drug prices. “The rising cost of prescription medicines is putting pressure on public and family budgets in the United States,”  is … Continue reading

Posted in Jill Zorn | Tagged , | 1 Comment

Warning: Pharmaceutical Advertising can be Hazardous to Your Health (and Wallet)

By Jill Zorn Connecticut Congresswoman Rosa DeLauro has introduced a bill called the “Responsibility in Drug Advertising Act,” which calls for a three-year moratorium on direct-to-consumer advertising of new medications approved by the Food and Drug Administration (FDA). This all in an effort … Continue reading

Posted in From the Foundation, Jill Zorn | Tagged , | 2 Comments

Big Pharma: Dangerous Practices Don’t End With Martin Shkreli

By Jill Zorn Last week was not a good week for Big Pharma. The poster-boy for bad behavior, Turing Pharmaceuticals CEO Martin Shkreli, was forced to back down from his outrageous price increase for a life-saving drug that AIDS patients … Continue reading

Posted in Jill Zorn | Tagged , | 1 Comment